A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months
Completed · Phase 2 · Has a placebo group
Conditions studied: Acute Otitis Media
In brief
The purpose of this study is to develop a better understanding of the safety, tolerability and efficacy of intranasal OP0201 as an adjunct treatment to oral antibiotics for the treatment of Acute Otitis Media (AOM) in infants and children.
Key facts
- Study ID
- NCT03818815
- Run by
- Novus Therapeutics, Inc
- People needed
- 103
- Starts
- 2019-02-21
- Expected to finish
- 2020-03-26
- Last updated by the study team
- 2020-08-18
Who can join
Age: 1 and older, up to 2. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UPMC Children's Hospital of Pittsburgh - General Academic Pediatrics Oakland Medical Building — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.